1. Home/
  2. Compounds/
  3. navitoclax:piperlongumine (1:1 mol/mol)

navitoclax:piperlongumine (1:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2navitoclax:piperlongumine (1:1 mol/mol)
PharmacoGx navitoclax:piperlongumine (1:1 mol/mol)

Cell lines tested with navitoclax:piperlongumine (1:1 mol/mol)

788 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
DU-145 prostate CTRPv22
AsPC-1 pancreas CTRPv22
NCI-H1869 lung CTRPv22
CCF-STTG1 central nervous system CTRPv22
OAW-28 ovary CTRPv22
HeLa cervix CTRPv22
LOXIMVI haematopoietic and lymphoid tissue CTRPv22
NCI-H520 lung CTRPv22
MKN74 stomach CTRPv22
Download CSV

Tissues tested with navitoclax:piperlongumine (1:1 mol/mol)

24 tissues have been tested with this compound, using data from 1 dataset(s).
haematopoietic and lymphoid tissueCTRPv2144
lungCTRPv2136
N/ACTRPv247
large intestineCTRPv245
skinCTRPv244
central nervous systemCTRPv244
ovaryCTRPv241
pancreasCTRPv240
breastCTRPv234
stomachCTRPv229
Download CSV
Download Data as CSV

Top molecular features associated with response to navitoclax:piperlongumine (1:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ARHGAP33 CTRPv2 AAC 0.31 3e-17
mRNA ZNF737 CTRPv2 AAC 0.28 1e-14
mRNA PRR36 CTRPv2 AAC 0.28 2e-14
mRNA SMAD4 CTRPv2 AAC 0.29 2e-14
mRNA RP11-729L2.2 CTRPv2 AAC 0.3 2e-14
mRNA VPS4B CTRPv2 AAC 0.26 3e-14
mRNA GRIK5 CTRPv2 AAC 0.27 6e-14
mRNA CELF4 CTRPv2 AAC 0.27 7e-14
mRNA SBK1 CTRPv2 AAC 0.28 7e-14
mRNA WDR7 CTRPv2 AAC 0.29 2e-13
Download CSV